Incessant infant ventricular tachycardia
diseaseOn this page
Summary
Incessant infant ventricular tachycardia (MONDO:0018685) is a disease. A subtype of cardiac rhythm disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 100 000 (Europe) [Orphanet-validated]
- Phenotypes (HPO): 12
Clinical features
Epidemiology
Prevalence records
4 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Point prevalence | 1-9 / 100 000 | Europe | Validated | |
| Prevalence at birth | 1-9 / 100 000 | 1.5 | Europe | Validated |
| Point prevalence | 1-9 / 1 000 000 | United Kingdom | Validated | |
| Prevalence at birth | 1-9 / 1 000 000 | 0.3 | United Kingdom | Validated |
Signs & symptoms
Clinical features (HPO)
12 HPO clinical features (Orphanet curated; top 12 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0004756 | Ventricular tachycardia | Obligate (100%) |
| HP:0001635 | Congestive heart failure | Very frequent (80-99%) |
| HP:0001695 | Cardiac arrest | Very frequent (80-99%) |
| HP:0006677 | Prolonged QRS complex | Very frequent (80-99%) |
| HP:0011710 | Bundle branch block | Very frequent (80-99%) |
| HP:0031595 | Abnormal P wave | Very frequent (80-99%) |
| HP:0001557 | Prenatal movement abnormality | Frequent (30-79%) |
| HP:0004755 | Supraventricular tachycardia | Frequent (30-79%) |
| HP:0005152 | Histiocytoid cardiomyopathy | Frequent (30-79%) |
| HP:0009729 | Cardiac rhabdomyoma | Frequent (30-79%) |
| HP:0001716 | Wolff-Parkinson-White syndrome | Occasional (5-29%) |
| HP:0025169 | Left ventricular systolic dysfunction | Excluded (0%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | incessant infant ventricular tachycardia |
| Mondo ID | MONDO:0018685 |
| Orphanet | 45453 |
| ICD-11 | 1364925734 |
| SNOMED CT | 233908008 |
| UMLS | C0340487 |
| MedGen | 573762 |
| GARD | 0018832 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of cardiac rhythm disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › heart disorder › cardiac rhythm disease › incessant infant ventricular tachycardia
Related subtypes (16): ventricular fibrillation, cardiac arrest, atrial fibrillation, ventricular tachycardia, atrial tachycardia, torsade-de-pointes syndrome with short coupling interval, sinoatrial node dysfunction and deafness, sino-auricular heart block, multifocal atrial tachycardia, His bundle tachycardia, ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, sudden arrhythmia death syndrome, cardiac conduction defect, sudden cardiac arrest, cardiac conduction disease with or without cardiomyoopathy, cardiogenetic rhythm disorder
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.